STERIS plc (NYSE:STE) Stock Holdings Trimmed by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its position in STERIS plc (NYSE:STE - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,493 shares of the medical equipment provider's stock after selling 2,893 shares during the quarter. New York State Teachers Retirement System owned 0.08% of STERIS worth $17,163,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Magnolia Capital Advisors LLC raised its holdings in shares of STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock worth $521,000 after purchasing an additional 48 shares during the period. SkyView Investment Advisors LLC raised its holdings in shares of STERIS by 1.6% in the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after purchasing an additional 51 shares during the period. Park Edge Advisors LLC raised its holdings in shares of STERIS by 1.1% in the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock worth $958,000 after purchasing an additional 51 shares during the period. Opal Wealth Advisors LLC raised its holdings in shares of STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock valued at $230,000 after buying an additional 60 shares during the period. Finally, Sage Private Wealth Group LLC raised its holdings in shares of STERIS by 4.1% during the 4th quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider's stock valued at $316,000 after buying an additional 61 shares during the period. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on STE. StockNews.com downgraded STERIS from a "strong-buy" rating to a "buy" rating in a report on Tuesday, October 29th. Stephens reiterated an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research note on Friday, November 8th. Finally, JMP Securities restated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $258.75.

STERIS Stock Down 0.0 %

NYSE STE traded down $0.09 during mid-day trading on Thursday, reaching $220.73. 249,643 shares of the company's stock traded hands, compared to its average volume of 476,156. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a fifty day simple moving average of $213.38 and a 200-day simple moving average of $223.66. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a market cap of $21.69 billion, a price-to-earnings ratio of 46.86 and a beta of 0.84.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts expect that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. STERIS's payout ratio is 48.41%.

Insider Transactions at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of STERIS stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now owns 11,372 shares in the company, valued at approximately $2,471,363.04. This trade represents a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.14% of the company's stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.